Indefinite Delivery Contract SPE2DB24D9203

The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract, SPE2DB, to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $499,999,999, has a period of performance through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. The products include flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, selenium sulfide lotion, neomycin and polymyxin antibiotics, surgical detergent solutions, artificial tears, testosterone gels, albumin solutions, and contraceptive products. This indefinite delivery contract complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.

DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic prescription and over-the-counter drug supplies globally. As a for-profit, woman-owned small business, the company is registered to receive federal contract awards from the U.S. government. Through this contract and others, DMS Pharmaceutical Group has provided a wide array of pharmaceutical products and medical supplies to U.S. government agencies, predominantly the Department of Veterans Affairs and the Department of Defense.